Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia

ClinicalTrials.gov ID: NCT01226667

Public ClinicalTrials.gov record NCT01226667. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 10:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01226667
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Osteoporosis Medical Center, Beverly Hills, CA
Other
Enrollment
174 participants

Conditions and interventions

Conditions

Interventions

  • Pregabalin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2010
Primary completion
Jun 30, 2012
Completion
Jun 30, 2012
Last update posted
Jul 30, 2012

2010 – 2012

United States locations

U.S. sites
5
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
David Silver MD Inc Beverly Hills California 90211
Stuart L Silverman MD Inc. Beverly Hills California 90211
Talbert Medical Group Huntington Beach California 92646
Catalina Pointe Clinial Research Tucson California 85704
Affilaites in Medical Specialty West Hills California 91307

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01226667, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2012 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01226667 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →